600227 Guizhou Chitianhua
- 1.43
- -0.05-3.38%
Guizhou Chitianhua News
Shengjitang (600227): The chemical business turned a loss into profit, and the pharmaceutical industry is still in the development period
Shengji Hall (600227): 2019 report and Q1 comments: asset impairment affects short-term performance to accelerate the focus on the main pharmaceutical industry
Red Tianhua (600227) In-depth Report: Focusing on the Pharmaceutical Industry to Build a Chronic Diabetes Management Platform
Comments on Chitianhua (600227) Annual report and Quarterly report: the chemical business is beginning to reverse and the pharmaceutical business is growing steadily.
Comments on Chitianhua (600227) Annual report: chemical business bottomed out and pharmaceutical business developed steadily
Comments on Chitianhua (600227) Quarterly report: chemical business is a drag on the company's growth. Western medicine business has a good momentum of growth.
Chitianhua (600227) in-depth report: chemical business gradually stabilizes and active layout of pharmaceutical industry
[Zheshang Securities] Chitianhua depth report: chemical business has gradually stabilized and actively laid out the pharmaceutical industry
[first Venture Securities] comments on Chitianhua semi-annual report: Jinchi Chemical Industry promotes the future development of the company.
[Huachuang Securities] Chitianhua Quarterly report Review: optimistic about the Development of New Coal Chemical Industry in the Future
【华创证券】赤天化:产业转型带来良好预期
【银河证券】赤天化:新项目推动公司业绩高增长
【银河证券】赤天化:被严重低估的化工龙头
【东海证券】赤天化:煤化工项目助公司华丽转身
[Donghai Securities] Chitianhua: rising natural gas prices squeeze urea profits
【东海证券】赤天化半年报点评:天然气区域龙头转向煤化工
【申银万国】赤天化:季报业绩符合预期,煤化工项目逐渐进入收获期
【群益证券】赤天化:转型煤化工企业,盈利逐年释放
【天相投资】赤天化:减值损失造成业绩下滑,一季度业绩不甚乐观
【申银万国】赤天化:年报业绩符合预期,煤化工项目逐渐进入收获期
Analysis
Price Target
No Data
